Heidi Ortolf-Wahl
Papers
1
Total Citations
14
H-Index
1
About
Heidi Ortolf-Wahl is a pioneering biomedical researcher whose work lies at the intersection of microphysiological systems and respiratory toxicology. Her primary research focus is the development of advanced in vitro models—particularly lung-on-chip platforms—to study the effects of inhaled pollutants and cigarette smoke on human lung tissue. Ortolf-Wahl’s major contribution is the creation of a next-generation smoke inhalation system integrated with a breathing lung-on-chip, which allows for continuous, physiologically relevant exposure to cigarette smoke. This model overcomes the limitations of traditional animal studies, which often fail to replicate human lung responses due to species-specific differences in anatomy and physiology. Her landmark 2025 paper on this system has already garnered 14 citations, signaling its rapid adoption as a transformative tool in respiratory disease research. By enabling real-time observation of cellular responses to smoke exposure, Ortolf-Wahl’s work is advancing our understanding of chronic obstructive pulmonary disease (COPD) and lung cancer pathogenesis. Her innovative approach positions her as a leader in the field of organ-on-chip technology, offering a more ethical and accurate alternative to animal testing for studying environmental lung injury.
Research Focus
Key Achievements
Top Papers
- 1